The percentage of fatally injured drivers who tested positive for prescription opioids rose sevenfold from 1 percent in 1995 to over 7 percent in 2015, according to a new study at Columbia University's Mailman School of Public Health.
A treatment program for adolescents with substance-use disorder that incorporates the practices and philosophy of 12-step programs like Alcoholics Anonymous produced even better results than the current state-of-the art treatment approach in a nine-month, randomized trial.
A University of Guelph-Humber funded study investigating mental health perceptions and practices of an aboriginal community in northern Ontario, and its significantly lower rates of mental health services utilization and suicide, suggests that a strong ethno-cultural identity and connection to the land are significant factors to positive mental health outcomes in this region. The study findings are published in the August 2017 edition of the International Journal of Mental Health and Addiction.
Fear of being arrested still undercuts an Indiana law that shields anyone who administers naloxone from criminal charges, according to a survey conducted by two researchers at Indiana University-Purdue University Indianapolis. Naloxone is a lifesaving emergency antidote for opioid overdose.
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which is published online ahead of print in JAMA Internal Medicine.
Years of sustained and coordinated efforts will be required to contain and reverse the harmful societal effects of the prescription and illicit opioid epidemics, which are intertwined and getting worse, says a new report from the National Academies of Sciences, Engineering, and Medicine.
The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study published in the American Journal of Psychiatry and led by Indiana University.
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information.
Rats missing a neuroreceptor that controls the release of the neurotransmitter glutamate are less amenable to the rewarding effects of cocaine, increasing their chance of kicking the habit once addicted, researchers from the US National Institute on Drug Abuse (NIDA) find. Their work, appearing July 11 in Cell Reports, suggests that the receptor, which protects nerve cells from fatal inundation by excess glutamate, is involved in modulating the reward-seeking behavior associated with drug addiction.
This point/counterpoint and editorial appear in the July/August 2017 issue of Annals of Family Medicine. Links will go live at 5 p.m. ET, July 10.